Strs Ohio Regeneron Pharmaceuticals, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 37,620 shares of REGN stock, worth $29.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

37,620

Previous 37,820 0.53%

Holding current value

$29.4 Million

Previous $39.7 Million 0.51%

% of portfolio

0.16%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $204,817 - $240,352	-200 Reduced 0.53%	37,620 $39.5 Million
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $21,196 - $25,708	24 Added 0.06%	37,820 $39.7 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $3.34 Million - $3.68 Million	3,704 Added 10.86%	37,796 $36.4 Million
Q4 2023 Jan 30, 2024	BUY	$775.18 - $881.7 $2.2 Million - $2.5 Million	2,837 Added 9.08%	34,092 $29.9 Million
Q3 2023 Oct 26, 2023	SELL	$692.45 - $844.37 $676,523 - $824,949	-977 Reduced 3.03%	31,255 $25.7 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $1.03 Million - $1.22 Million	-1,473 Reduced 4.37%	32,232 $23.2 Million
Q1 2023 Aug 02, 2023	BUY	$680.49 - $826.97 $1 Million - $1.22 Million	1,473 Added 4.57%	33,705 $27.7 Million
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $226,603 - $275,381	-333 Reduced 0.98%	33,705 $27.7 Million
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $571,065 - $620,009	-809 Reduced 2.32%	34,038 $24.6 Million
Q3 2022 Oct 27, 2022	SELL	$573.97 - $724.32 $667,527 - $842,384	-1,163 Reduced 3.23%	34,847 $24 Million
Q2 2022 Jul 25, 2022	SELL	$548.35 - $738.84 $2.54 Million - $3.43 Million	-4,639 Reduced 11.41%	36,010 $21.3 Million
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $2.64 Million - $3.1 Million	4,439 Added 12.26%	40,649 $28.4 Million
Q4 2021 Jan 24, 2022	SELL	$543.48 - $670.97 $5 Million - $6.17 Million	-9,194 Reduced 20.25%	36,210 $22.9 Million
Q3 2021 Oct 22, 2021	SELL	$574.03 - $680.96 $1.76 Million - $2.09 Million	-3,069 Reduced 6.33%	45,404 $27.5 Million
Q2 2021 Jul 26, 2021	BUY	$472.8 - $558.54 $252,002 - $297,701	533 Added 1.11%	48,473 $27.1 Million
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $3.08 Million - $3.78 Million	-6,894 Reduced 12.57%	47,940 $22.7 Million
Q4 2020 Jan 25, 2021	BUY	$478.3 - $607.98 $2.39 Million - $3.04 Million	5,003 Added 10.04%	54,834 $26.5 Million
Q3 2020 Dec 14, 2020	SELL	$544.75 - $658.21 $1.38 Million - $1.66 Million	-2,525 Reduced 4.82%	49,831 $27.9 Million
Q2 2020 Jul 23, 2020	BUY	$493.32 - $643.92 $4.65 Million - $6.07 Million	9,434 Added 21.98%	52,356 $32.7 Million
Q1 2020 Apr 23, 2020	BUY	$336.18 - $494.43 $527,466 - $775,760	1,569 Added 3.79%	42,922 $21 Million
Q4 2019 Jan 24, 2020	SELL	$274.13 - $376.51 $844,868 - $1.16 Million	-3,082 Reduced 6.94%	41,353 $15.5 Million
Q3 2019 Oct 21, 2019	SELL	$273.46 - $318.39 $422,769 - $492,230	-1,546 Reduced 3.36%	44,435 $12.3 Million
Q2 2019 Jul 25, 2019	BUY	$299.6 - $414.82 $79,094 - $109,512	264 Added 0.58%	45,981 $14.4 Million
Q1 2019 Apr 19, 2019	BUY	$372.08 - $439.57 $332,267 - $392,536	893 Added 1.99%	45,717 $18.8 Million
Q4 2018 Jan 23, 2019	BUY	$335.82 - $403.04 $372,760 - $447,374	1,110 Added 2.54%	44,824 $16.7 Million
Q3 2018 Oct 19, 2018	SELL	$351.14 - $408.51 $1.22 Million - $1.42 Million	-3,486 Reduced 7.39%	43,714 $17.7 Million
Q2 2018 Aug 06, 2018	SELL	$284.6 - $344.99 $379,087 - $459,526	-1,332 Reduced 2.74%	47,200 $16.3 Million
Q1 2018 Apr 20, 2018	SELL	$315.82 - $393.78 $265,288 - $330,775	-840 Reduced 1.7%	48,532 $16.7 Million
Q4 2017 Jan 23, 2018	SELL	$358.63 - $469.95 $258,930 - $339,303	-722 Reduced 1.44%	49,372 $18.6 Million
Q3 2017 Oct 23, 2017	BUY	$431.38 - $504.0 $21.6 Million - $25.2 Million	50,094	50,094 $22.4 Million

Others Institutions Holding REGN

# of Institutions

1,524

Shares Held

84M

Call Options Held

1.14M

Put Options Held

1.48M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account